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AbstrAct
IL-4 and IL-13 are closely related canonical type-2 cytokines in mammals and 
have overlapping bioactivities via shared receptors. They are frequently activated 
together as part of the same immune response and are the signature cytokines 
produced by T-helper (Th)2 cells and type-2 innate lymphoid cells (ILC2), mediating 
immunity against extracellular pathogens. Little is known about the origin of type-
2 responses, and whether they were an essential component of the early adaptive 
immune system that gave a fitness advantage by limiting collateral damage caused 
by metazoan parasites. Two evolutionary related type-2 cytokines, IL-4/13A and 
IL-4/13B, have been identified recently in several teleost fish that likely arose by 
duplication of an ancestral IL-4/13 gene as a consequence of a whole genome 
duplication event that occurred at the base of this lineage. However, studies of their 
comparative expression levels are largely missing and bioactivity analysis has been 
limited to IL-4/13A in zebrafish. Through interrogation of the recently released 
salmonid genomes, species in which an additional whole genome duplication event 
has occurred, four genomic IL-4/13 loci have been identified leading to the cloning 
of three active genes, IL-4/13A, IL-4/13B1 and IL-4/13B2, in both rainbow trout 
and Atlantic salmon. Comparative expression analysis by real-time PCR in rainbow 
trout revealed that the IL-4/13A expression is broad and high constitutively but 
less responsive to pathogen-associated molecular patterns (PAMPs) and pathogen 
challenge. In contrast, the expression of IL-4/13B1 and IL-4/13B2 is low 
constitutively but is highly induced by viral haemorrhagic septicaemia virus (VHSH) 
infection and during proliferative kidney disease (PKD) in vivo, and by formalin-killed 
bacteria, PAMPs, the T cell mitogen PHA, and the T-cell cytokines IL-2 and IL-21 
in vitro. Moreover, bioactive recombinant cytokines of both IL-4/13A and B were 
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IntroductIon
Mammalian interleukin (IL)-4 and IL-13 were 
among the first cytokines described in the early 1980s 
[1-2]. IL-4 was initially identified as a T cell-derived 
B cell growth factor [3] and an immunoglobulin (Ig) 
switch factor for IgG1 [4] and IgE [5], and was later 
found to act also on T cells, mast cells [6], macrophages, 
cells of the myeloid and erythroid lineages, and non-
hemopoietic cells [7]. In 1989, IL-13, a close congener 
of IL-4, was found to mediate virtually all of the IL-4 
actions on non-haematopoietic cells and to some degree 
on haematopoietic cells [8]. Although they share low 
amino acid sequence identity, eg 23% in humans and 22% 
in cow, IL-4 and IL-13 are indeed closely related. They 
sit side by side in the mammalian genome and form part 
of a contiguous gene cluster sharing regulatory elements, 
and are frequently activated together as part of the same 
immune response [1, 9-10]. They function not only in the 
immune system but also in pregnancy, fetal development, 
mammary development and lactation, and in higher brain 
functions including memory and learning in mammals 
[11].
In the mammalian immune system, IL-4 and IL-13 
are type-2 cytokines that drive canonical type-2 immunity, 
characterised by eosinophilia, mast cell hyperplasia, 
IgE secretion, smooth muscle contraction and epithelial 
remodelling [1, 9, 12-13]. These responses offer protection 
against helminth parasites but can also be damaging when 
activated inappropriately, leading to type-2 inflammatory 
conditions such as allergy and asthma [13-15]. IL-4 and 
IL-13 are produced by CD4+ T-helper type 2 (Th2) cells, 
effecting host immunity against extracellular parasites. 
The canonical type-2 cytokine-induced responses are 
mediated via STAT (Signal Transducer and Activator of 
Transcription)6/GATA3. The binding of IL-4 or IL-13 to 
their receptors results in the phosphorylation of STAT6, 
which dimerizes, translocates to the nucleus and induces 
GATA3 expression. This signaling pathway creates 
a positive feedback loop to maintain IL-4 and IL-13 
production in Th2 cells. Thus, GATA3 promotes type-
2 cytokine expression, and additionally auto-activates 
its own transcription thereby stabilizing the Th2 fate 
[16]. IL-4 and IL-13 production in Th cells can also be 
potentiated by non-canonical pathways, as seen with IL-2 
that can drive IL-4 transcription in an IL-4R-independent 
manner through the phosphorylation of STAT5 [17]. 
In addition to production of IL-4 and IL-13 by 
mammalian Th2 cells, innate immune cells (eg basophils, 
eosinophils and mast cells) constitutively express both 
molecules and represent important sources of type-2 
cytokines early during type-2 immunity [18-20]. These 
cells can rapidly release cytokines within 5-10 min, due 
to the presence of pre-formed type-2 cytokines in their 
secretory granules, and can also generate cytokines 
de novo following stimulation [21]. Furthermore, 
invariant Natural Killer T cells, a population of innate T 
lymphocytes, and type-2 innate lymphoid cells (ILC2) 
are also implicated as a major source of IL-4 and IL-13 
production in vivo [22-23].
IL-4 and IL-13 signal through cell surface 
heterodimeric receptors composed of 3 possible subunits, 
IL-4Rα, IL-13Rα1 and the common-γ chain (γC). IL-4 
signals through both the type I receptor composed of the 
IL-4Rα and γC, and the type II receptor composed of the 
IL-4Rα and IL-13Rα1, whilst IL-13 only signals through 
the type II receptor [1, 9]. IL-4 binds IL-4Rα with very 
high affinity (KD = 20-300 pM), leading to the recruitment 
of either γC or IL-13Rα1, that both have lower, 
approximately equal affinity for the IL-4:IL-4Rα complex 
(KD = 500 nM). Binding of IL-4 to the type I receptor 
complex activates JAK1/3. In contrast, IL-13 binds to IL-
13Rα1 with moderate affinity (KD = 30 nM) relative to 
the IL-4:IL-4Rα interaction, leading to recruitment of the 
IL-4Rα subunit and activation of JAK1 or JAK2/TYK2. 
IL-13 can also bind with extraordinarily high affinity [ < 
10−15 M,] to IL-13Rα2, which is believed to be a “decoy” 
receptor for IL-13 owing to its lack of a cytoplasmic tail 
produced and found to have shared but also distinct bioactivities. Both cytokines rapidly 
induce the gene expression of antimicrobial peptides and acute phase proteins, providing 
an effector mechanism of fish type-2 cytokines in immunity. They are anti-inflammatory 
via up-regulation of IL-10 and down-regulation of IL-1β and IFN-γ. They modulate the 
expression of cellular markers of T cells, macrophages and B cells, the receptors of IFN-γ, 
the IL-6 cytokine family and their own potential receptors, suggesting multiple target cells 
and important roles of fish type-2 cytokines in the piscine cytokine network. Furthermore 
both cytokines increased the number of IgM secreting B cells but had no effects on the 
proliferation of IgM+ B cells in vitro. Taken as a whole, fish IL-4/13A may provide a basal 
level of type-2 immunity whilst IL-4/13B, when activated, provides an enhanced type-2 
immunity, which may have an important role in specific cell-mediated immunity. To our 
knowledge this is the first in-depth analysis of the expression, modulation and bioactivities 
of type-2 cytokines in the same fish species, and in any early vertebrate. It contributes to a 
broader understanding of the evolution of type-2 immunity in vertebrates, and establishes 
a framework for further studies and manipulation of type-2 cytokines in fish.
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and signaling motifs [24]. The IL-4 and IL-13 receptor 
subunits are expressed at low levels under normal 
homeostatic conditions, but are influenced by hormones, 
cellular/oxidative stress, infection and inflammation 
[25]. Whilst the IL-4Rα and IL-13Rα1 chains are widely 
expressed at low levels on most cell types, the γC chain 
is primarily expressed on hematopoietic immune cells 
[9]. Therefore, the availability of each receptor subunit 
on the cell surface, and concentration of IL-4 vs. IL-13 in 
the extracellular milieu are important determinants of the 
signaling pathway activated within the responding cells [1, 
9]. IL-4 and IL-13 can elicit overlapping but also unique 
biological responses. For example, in the pathogenesis 
of allergic asthma, IL-4 and IL-13 play an important 
role in tandem, with IL-4 having a pivotal role in Th2 
cell proliferation, cytokine production and IgE synthesis, 
whilst IL-13 plays a pivotal role in the effector phase of 
the disease [14]. 
Little is known about the origin of type-2 responses, 
and whether they were an essential component of the early 
adaptive immune system that gave a fitness advantage by 
limiting collateral damage caused by metazoan parasites. 
In addition, whilst Th2 responses have been known for 
a long time [2] there are still many questions relating to 
the mechanisms that initiate and control these responses 
in mammals [26], which comparative studies in other 
vertebrates may aid. All the receptor subunits of IL-4 
and IL-13 (IL-4Rα, γC, IL-13Rα1 and IL-13Rα2) exist 
throughout the jawed vertebrates [10], with two copies 
of each present in salmonids [27-29]. IL-4 and IL-13 are 
present in mammals and birds but clear orthologues of 
IL-4 or IL-13 are missing in other vertebrates [10]. The 
first IL-4/IL-13 related gene was identified adjacent to 
RAD50 in the pufferfish (Tetraodon nigroviridis) genome 
by Li and colleagues [30]. A second IL-4/IL-13 like gene 
was discovered in zebrafish (Danio rerio) at a different 
locus (adjacent to KIF3A) [31]. Subsequent analysis of 
the two loci has revealed that they most likely arose as 
a consequence of the third round (3R) whole genome 
duplication (WGD) event that happened in the teleost 
fish ancestor. Hence, the two genes were called IL-4/13A 
(adjacent to RAD50) and IL-4/13B (adjacent to KIF3A) 
[32]. More recently a single IL-4/13 gene was identified in 
the genome of the 2R bony fish, spotted gar (Lepisosteus 
oculatus) between KIF3A and RAD50 [10], and at least 
two IL-4/13 genes have been found between KIF3A and 
RAD50 in the elephant shark (Callorhinchus milii), a 2R 
cartilaginous fish [33-34]. It seems likely that a single 
IL-4/IL-13 gene existed in ancestral Gnathostomes, which 
has been duplicated in different lineages by WGD and/or 
tandem duplication events [10].
To date, functional analysis of IL-4/13A and 
IL-4/13B in fish is limited. The tetraodon IL-4/13A 
exhibits constitutive expression in most tissues studied, 
being higher in gills, brain, muscle and heart [30]. High 
constitutive expression of IL-4/13A has been found in 
salmonid mucosal tissues (gill, skin) [35]. In addition, IL-
4/13A has been found to be up-regulated in rainbow trout 
Oncorhynchus mykiss epidermis 9 days post-infection 
with Ichthyobodo necator compared with uninfected fish 
[36]. Interestingly, a cell line (KoThL5) that expresses IL-
4/13B has been established from carp (Cyprinus carpio) 
[37]. These cells also express TCR chains, and a CD4-
like molecule (termed CD4-1), a phenotype similar to 
mammalian Th2 cells. Bioactivity analysis has only been 
carried out using recombinant zebrafish IL-4/13A [38-39]. 
Administration of IL-4/13A in vivo increased the numbers 
of peripheral blood leucocytes that express the IgZ-2 
isoform after two days, or DC-SIGN after 5 days [38], and 
significantly upregulated B cell proliferation and antibody 
production [39]. The bioactivity of IL-4/13B is unknown 
in any fish species, and the comparative expression and 
modulation of both IL-4/13A and B paralogues in the same 
species is currently lacking.
In this study, we first identified four IL-4/13 
genomic loci in the salmonid genome, that enabled the 
cloning of three active genes, IL-4/13A, B1 and B2. 
Comparative transcriptional analysis was undertaken in 
tissues from healthy fish, in cell lines and purified immune 
cells, and during parasitic, viral and bacterial infections. 
Bioactive recombinant proteins were generated for all 
the three trout IL-4/13 isoforms. Functional analysis 
revealed overlapping yet distinct functionalities in terms 
of transcriptional modulation of other immune genes and 
their impact on B cell populations. 
results
Salmonids possess three active fish-specific Th2 
cytokines, IL-4/13A, IL-4/13B1 and IL-4/13B2, 
and an IL-4/13A pseudogene
Three IL-4/13 cDNA sequences with complete 
coding sequence (CDS) have been cloned in both rainbow 
trout and Atlantic salmon Salmo salar that match genomic 
sequences in the database (Supplementary Figures S1-S2 
and 4-7, and Table 1). According to homology and linkage 
to RAD50 and KIF3A [1, 32] (Figure 1 and Table 1), they 
have been named as IL-4/13A, IL-4/13B1 and IL-4/13B2, 
with the likelihood that the last two genes have originated 
from the salmonid 4R WGD event [40]. Each gene has 
a potential polyadenylation signal and between 2 and 4 
ATTTA motifs in the 3’-untranlated region (UTR). An in 
frame stop codon is also apparent in the 5’-UTR in all the 
genes, except salmon IL-4/13B2 (Figures S1-S2 and 4-7, 
and Table 1). 
A Whole Genome Shotgun (WGS) sequence contig 
(Acc. no. AGKD03032511) was also identified in Atlantic 
salmon that had a putative exon corresponding to the 
last exon of the IL-4/13A gene (designated as IL-4/13p). 
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This exon, when translated, has 48.7% identity to the 
last exon of salmon IL-4/13A and 61.5% identity to that 
of trout IL-4/13A, and has a potential polyadenylation 
signal (Figure S3). However, a canonical intron acceptor 
site (AG) is missing at the intron junction and ATTTA 
motifs are missing in the putative 3’-UTR that are present 
in the 3’-UTR of all the other salmonid IL-4/13 genes. 
No other IL-4/13 exons could be identified upstream of 
this last exon. Furthermore, this putative exon sits in a 
syntenically conserved locus, with the salmonid IL-4/13A 
gene downstream of genes including POU4F3, RBM27 
and LARS (Figure 1). Such evidence suggests it originated 
from a decayed IL-4/13A gene after the salmonid 4R 
WGD event [40].
Figure 1: Gene synteny at the Th2 loci across vertebrates. The KIF3A/IL-4/IL-13/RAD50 loci were analysed using the Genomicus 
program (genomicus, database release-78.01). The information for frog and elephant shark is extracted from NCBI genomic sequence 
NW_004668234 (frog Xenopus (Silurana) tropicalis) and NW_006890145 (shark Callorhinchus milii). The spotted gar locus was used as 
a reference with conserved genes colour-matched. The salmonid IL-4/13 loci were derived from the WGS contigs of Atlantic salmon and 
rainbow trout (Table 1).
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The salmonid IL-4/13 genes encode proteins of 142-
153 aa, with predicted signal peptides of 17-24 aa, mature 
peptides of 119-136 aa, and 0-3 potential N-glycosylation 
sites (Figures S1-S2, S4-S7; Table 1). The mature peptides 
of salmonid IL-4/13 isoforms have theoretical molecular 
weights of 13.69-15.33 kDa. All trout IL-4/13 isoforms 
have a basic pI (7.20-7.90). Salmon IL-4/13A is also 
basic (pI = 8.72), but the two salmon IL-4/13B isoforms 
are acidic (pI = 6.72 for B1 and 4.91 for B2) (Table 1). 
The salmonid IL-4/13 isoforms have four conserved 
cysteine residues with two additional cysteine residues 
at the C-terminal of salmonid IL-4/13B2 (Figure S8). 
The aa identities of the trout and salmon molecules are 
highest (81.5-82.4%) between the orthologues of salmonid 
IL-4/13 isoforms from the 4R WGD (isoforms A, B1 or 
B2), although this is relatively low compared to other 
cytokines. Moderate identity (61.8-66.0%) is seen between 
the paralogues from the 4R WGD (between B1 and B2) 
and only low identity (26.3-29.3%) is seen between the 
paralogues from the 3R WGD (between A and B, Table 1).
Sequence analysis reveals lineage-specific 
evolution
Amino acid identity/similarity analysis between 
fish IL-4/13 molecules, tetrapod IL-4 and IL-13, and other 
γ-chain cytokines revealed the salmonid IL-4/13A and B 
isoforms to have similar identities/similarities to other 
IL-4/IL-13 molecules from different lineages (Table S1). 
Salmonid IL-4/13 isoforms share relatively low identity 
(24-25%) to the predicted IL-4/13 from the spotted gar 
(a 2R bony fish) and the IL-4/13 molecules from (3R) 
cyprinids and percomorphs. Even lower identities were 
seen compared to homeotherm IL-4 and IL-13 (18-21%), 
and to other mammalian γ-chain cytokines (17-20%) 
(Table S1).
To see whether the salmonid molecules allow 
a greater insight into IL-4/13 evolution, a neighbour-
joining phylogenetic tree was constructed based on a 
multiple alignment of fish IL-4/13, tetrapod IL-4 and 
IL-13, and other closely related γ-chain cytokines (IL-
2, IL-9 and IL-21) (Figure S9). The salmonid IL-4/13 
molecules, along with the IL-4/13 molecules from other 
vertebrates, and tetrapod IL-4 and IL-13 formed a large 
cluster with 94% bootstrap support, which was separated 
from other closely related γ-chain cytokines, suggesting 
Table 1: Summary of sequence analysis of salmonid IL-4/13 genes
Note:
a. Salmon IL-4/13A cDNA was retrieved from the database.
b. pI of predicted mature peptides.
c. Theoretical molecular weight (kDa) of the predicted mature peptides.
d. Potential N-glycosylation sites.
e. The identities of salmonid orthologues of IL-4/13A, B1 and B2 are in bold.
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that all the IL-4/13 genes are indeed related to tetrapod 
IL-4 and IL-13 as suggested by the synteny analysis 
(Figure 1). Lineage-specific groups, eg IL-4 and IL-13 
from mammals and birds, and IL-4/13A and IL-4/13B 
from salmonids, cyprinids and percomorphs, are well 
supported. However, fish orthologue-specific groupings, 
as seen in phylogenetic trees of IL-1β [41], TNFα [42] and 
the sub-units of IL-12 [43] are missing (Figure S9). The 
topology of the phylogenetic tree is in agreement with the 
homology analysis (Table S1) in which aa identities within 
orthologues (eg IL-4/13A) are no higher than between 
paralogues (eg IL-4/13A and B), suggesting fast-evolution 
of the IL-4/13 related genes in vertebrates. 
To study further the apparent rapid evolution of the 
vertebrate IL-4/13 related genes, we analysed their gene 
organisation. Homeotherm IL-4 and IL-13, the 3R and 4R 
bony fish IL-4/13A and IL-4/13B, and the 2R vertebrate 
(shark, gar, amphibian) IL-4/13 genes all have a four 
coding exon/three phase 0 intron organisation (Figure 2). 
However, exon 3 appears to be lineage-specific. Exon 3 is 
larger in tetrapod IL-4 (126-177 bp) than in IL-13 (105-
114 bp), with exon 3 of IL-4/13 genes in 2R vertebrates 
Figure 2: Comparison of the gene organisation of salmonid IL-4/13 genes with IL-4, IL-13 and related genes from 
other vertebrates. The boxes represent amino acid coding regions and the black bars represent introns. The sizes (bp) of the coding 
regions are numbered in the boxes. The gene organisation of the salmonid IL-4/13 genes was predicted using the Spidey program based 
on the sequence information from Tables 1 and Figures S1-S2 and S4-S7. Other genes were extracted from NCBI genomic sequences 
NW_004668234 (frog IL-4/13) and NW_006890145 (elephant shark IL-4/13-1 and -2) and spotted gar chromosome LG6 (gar IL-4/13). 
Sequence data representing all other genes was reported by Ohtani et al. [32].
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Figure 3: Multiple alignment of mammalian IL-4 and IL-13, and IL-4/13 related molecules from 3R bony fish and 
other vertebrates A and the patterns of cysteine residues and connectivity prediction in different vertebrate groups. 
A. The exon-specific multiple alignment was produced using ClustalW. The accession numbers of the amino acid sequences used are as in 
Figure 2. The four exons are separated and marked above the alignment. The signal peptide, four α-helices and loops known in human IL-4 
are marked above human IL-4. The nine cysteine residues conserved in different lineages are denoted under the alignment. B. The lineage 
specific conserved cysteine residues are schematically shown relative to the four helical structure of human IL-4. The known disulfide-
bonds [47-48] in human IL-4 and IL-13 are shown by black lines and the predicted disulfide bonds [49] are indicated by red-lines.
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being of intermediate size (120-129 bp). Salmonid IL-
4/13A genes, in contrast to 3R fish species, possess a 
smaller exon 3. Exon 3 of human IL-4 encodes for helices 
B and C of the mature peptide, with helix C having an 
important role in IL-4 binding to its high affinity receptor 
chain, IL-4Rα [45-46]. Thus, lineage-specific exon 3 may 
contribute to the lineage specific diversification of IL-4/13 
genes and may have had an impact on the functional role 
of IL-4/13A and IL-4/13B in different lineages/species.
To gain further insights into potential functional 
diversification of IL-4/13 molecules, a multiple alignment 
based on exon and secondary structure was generated. In 
human IL-4 exon 1 encodes for the signal peptide and helix 
A, whilst exon 2 encodes the A-B loop, exon 3 helices B 
and C, and the B-C turn, and exon 4 the C-D loop and 
helix D [46] (Figure 3A). Nine cysteine residues can be 
identified in the multiple alignment that are conserved in 
a lineage-specific manner (Figure 3B). Human IL-4 and 
IL-13 are known to be four-helical cytokines stabilised 
by two conserved disulfide bonds [47-48]. Predictions of 
cysteine connectivities using DISULFIND [49] in IL-4/13 
molecules from fish and other vertebrates (Figure S10) 
suggest that lineage/species-specific disulfide bonds may 
have evolved to stabilise IL-4/13 molecules (Figure 3B).
Comparative transcript expression analysis of the 
three trout Th2 cytokines
The constitutive expression of the three trout 
Th2 cytokines was comparatively studied in tissues of 
apparently healthy fish, in cell lines, head kidney (HK) 
cells, primary HK macrophages, and purified IgM+ B 
cells (Figure 4). The expression of all three isoforms was 
detectable by real-time RT-PCR in all 17 tissues examined, 
with the expression of IL-4/13B2 in liver tissue being the 
lowest. The apparently highest expression of IL-4/13A 
was found in certain immune tissues/organs (gills, blood 
and thymus), as well as in tail fins and adipose fin. The 
apparently highest expression of IL-4/13B1 was also 
Figure 4: Constitutive expression of trout IL-4/13A, B1 and B2 in vivo in tissues A, in cell lines and purified immune 
cells B and the ratios of expression levels between each other. A. The transcript expression level of the three trout IL-4/13 
paralogues was determined by real time RT-PCR in 17 tissues from six fish. The transcript level was calculated using a serial dilution of 
references that contained equal molar amounts of the probes for each gene and was normalized against the expression level of EF-1α. The 
results represent the average +SEM of six fish. B. Total RNA was prepared from cell lines, 4-day old primary HK macrophages, FACS 
sorted spleen IgM+ B cells, and HK cells after 4 h culture in vitro. The expression analysis was as described in A.. The results represent 
the average + SEM from four flasks of cells or fish. A paired sample t-test was applied to the tissue samples, macrophages and HK cells, 
and one-way ANOVA was used for the cell lines. The expression levels between IL-4/13A, B1 and B2 in the same tissues or cell lines are 
significantly different (p < 0.05) when the letters over the bars are different. C. The ratio of the expression levels between each of the IL-
4/13 paralogues. HK = head kidney, AT = adipose tissue, CK = caudal kidney, AF = adipose fin; TF = tail fins, MФ = primary macrophages.
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in gills and thymus, as well as in tail fins, adipose fin, 
muscle, gonad and brain (Figure 4A). The expression of 
IL-4/13A was significantly higher (p < 0.05) than that of 
IL-4/13B1 and IL-4/13B2 in all tissues except muscle 
where the expression of IL-4/13A and IL-4/13B1 was not 
significantly different (Figure 4A, 4C). The expression of 
IL-4/13B1 was also significantly higher (p < 0.05) than 
that of IL-4/13B2 in all tissues with the exception of 
gills, spleen, HK and intestine, important immune tissues/
organs in fish (Figure 4A, 4C). It is noteworthy that the 
expression of the IL-4/13B paralogues was particularly 
low in immune relevant tissues such as HK, blood and 
intestine relative to IL-4/13A (Figure 4A).
In agreement with the high level expression in 
all the tissues examined, IL-4/13A expression was also 
detectable in all four cell lines, primary macrophages, 
HK cells and purified IgM+ B cells (Figure 4B). However, 
the expression of IL-4/13B1 and B2 was not detectable 
in RTL, RTG-2, RTGill cells or purified B cells, but was 
detectable in HK cells, primary macrophages and the 
macrophage-like cell line RTS-11. The expression of IL-
4/13A was significantly higher (p < 0.05) than that of IL-
4/13B1 and IL-4/13B2 in RTS-11 cells and in HK cells, 
and IL-4/13B2 in primary macrophages (Figure 4B, 4C).
The kinetics of expression of the three trout Th2 
cytokines after viral haemorrhagic septicaemia 
virus (VHSV) infection
Viral haemorrhagic septicaemia is one of the most 
important viral diseases of salmonid fish in European 
aquaculture caused by VHSV [50]. To gain an insight into 
their role in the host immune response to pathogens, we 
first investigated gene expression during VHSV infection. 
IL-4/13A expression did not exhibit any significant 
changes in the control fish, however the expression of IL-
4/13B1 and B2 increased over time in control fish with a 
significant increase at day 4 for IL-4/13B1 and at days 4 
and 7 for IL-4/14B2 (Figure 5), suggesting that operational 
stress could modulate IL-4/13B1 and B2 expression to 
some extent. VHSV exposure resulted in a significant 
increase in IL-4/13B1 and B2 expression in the kidney 
during the early stages post infection (eg 1 to 5 days for 
IL-4/13B1, and 1-4 days for IL-4/13B2) that peaked at 
day 3 with a 26.3-fold increase for IL-4/13B2. IL-4/13A 
expression also increased but to a lesser extent (up to 2.8-
fold) and only at days 4 and 5 (Figure 5).
Figure 5: Modulation of the expression of trout IL-4/13A, B1 and B2 in kidney by VHSV infection. Rainbow trout were 
infected by intraperitoneal (i.p.) injection with 100 µl of VHSV (DK-F1, 1 x 109 TCID
50
 /ml) while the control fish were mock-infected 
with the same amount of control media. Fish were sampled at 1 2, 3, 4, 5, 7, 9 and 12 days post challenge, when the kidney was removed 
for RNA preparation and real-time RT-PCR as described in Figure 4. The relative expression of IL-4/13 paralogues was normalized to the 
expression of EF-1α, and expressed as arbitrary units where one unit equals the average expression level of the mock-infected fish at day 
1 post infection. The results represent the mean + SEM of four fish. The relative significance of a LSD post hoc test after a significant one 
way-ANOVA between the VHSV and mock-injected groups at the same time point is shown above the bars as: *p < 0.05, **p < 0.01 and 
***p < 0.001. The numbers above the bars are the fold changes, calculated as the average expression level of VHSV infected fish divided 
by that of the time-matched controls. The arrow heads indicate significant increases (*p < 0.05) in the control fish relative to control fish 
at day 1.
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The expression of the three trout Th2 cytokines 
during proliferative kidney disease (PKD)
PKD is a parasitic disease of salmonid fish caused 
by the myxozoan parasite Tetracapsuloides bryosalmonae 
[51]. The expression profiles of trout IL-4/13 paralogues 
were also investigated in the kidney of fish with clinical 
PKD relative to uninfected controls. The infected fish 
were sampled from a natural outbreak and the severity 
of kidney clinical pathology was assigned a swelling 
grade of 1-3 [51]. The expression of IL-4/13B1 and B2 
was upregulated at grade 1, relative to control (grade 0) 
fish and to a greater extent in fish with advanced disease 
pathology (grades 1-2, 2 and 3) up to 13.7-fold (IL-
4/13B1) or 87.2-fold (IL-4/13B2) (Figure 6B and 6C). In 
contrast, IL-4/13A expression was only increased 2.2-fold 
in grade 1-2 fish (Figure 6A).
Modulation of the expression of the three trout 
Th2 cytokines in vivo by vaccination and bacterial 
challenge 
Enteric redmouth disease (ERM) is a serious 
septicaemic bacterial disease of salmonid fish species 
caused by Yersinia ruckeri, a Gram-negative rod-
shaped enterobacterium. It can be prevented by bacterin 
vaccination [53]. Mammalian IL-4 and IL-13 are key 
adaptive cytokines. Thus, we examined the expression of 
trout IL-4/13A, B1 and B2 in vivo after bacterial challenge 
using an effective bacterial vaccination model in fish. The 
ERM vaccine protects the vaccinated fish from challenge 
and modulates the expression of adaptive cytokines 
involved in Th1 [53] and Th17 [54] type responses. An 
i.p. vaccination was performed as this is known to give a 
high degree of protection in the host, and when combined 
with an i.p. challenge means there is a clear contrast 
between control and vaccinated fish in terms of expecting 
them to live or die. In this way individual sample variation 
is reduced. Two important immune tissues, the HK and 
gills were used for gene expression analysis. The gills 
are an important site for ERM infection [53] and show 
high expression of all of the IL-4/13 paralogues, as shown 
in Figure 4 and by others [35]. The HK is the central 
immune organ of fish. Naïve fish started to show disease 
symptoms and to die from day 3 post bacterial infection. 
Thus, we focussed on early times post-infection. Gene 
transcriptional levels were expressed as arbitrary units 
where one unit in each tissue equals the average expression 
level in the PBS injected control group at 6 h (Figure 7). 
In naïve control fish, Y. ruckeri challenge resulted in a 
down-regulated expression in the gills of IL-4/13A (at 48 
h), IL-4/13B1 (at 24 h, 48 h and 72 h) and IL-4/13B2 (at 
72 h), and in the HK of IL-4/13B1 at 48 h post challenge 
(Figure 7). In vaccinated fish, Y. ruckeri challenge did not 
alter the expression of IL-4/13A, B1 and B2 in both tissues 
examined at early stages (6 h, 24 h and 48 h). However at 
72 h, the expression of IL-4/13B1 and B2 in gills and HK, 
and of IL-4/13A in HK, was lower in Y. ruckeri challenged 
vaccinated fish compared to vaccinated and PBS injected 
fish (Figure 7). Interestingly, the expression of IL-4/13B1 
was higher in vaccinated fish than in naïve fish during the 
early infection phase (24 h and 48 h) in both gills and HK. 
Similarly, the expression of IL-4/13A and IL-4/13B2 was 
also higher in gills at 48 h post-challenge (Figure 7). 
Modulation of the expression of the three trout 
Th2 cytokines in primary macrophages and HK 
cells
To gain a further insight into IL-4/13 expression 
and modulation, we performed an expression analysis 
in vitro using HK cells and primary macrophages that 
are known to express all the three IL-4/13 paralogues 
(Figure 4). Bacterial infection had a negative effect on 
the expression of IL-4/13 paralogues in vivo (Figure 7). 
We, therefore, anticipated that host immune cells, such as 
HK cells that are a mixed population containing T cells, 
B cells, macrophages, neutrophils and others, should be 
modulated to express IL-4/13 paralogues in response 
to bacterial PAMPs (pathogen-associated molecular 
patterns). Thus HK cells were stimulated with formalin 
killed Renibacterium salmoninarum (a Gram positive 
bacterium that is the aetiological agent of bacterial 
kidney disease), Y. ruckeri and Aeromonas salmonicida 
(Gram negative bacteria, the latter being the aetiological 
agent of furunculosis), as well as with a non-pathogenic 
bacterium Arthrobacter davidanieli (used as a live vaccine 
for R. salmoninarum) [55]. A. davidanieli stimulation of 
HK cells markedly induced the expression of IL-4/13B 
paralogues from 4 h to 96 h, that peaked at 24 h with an 
increase of 53.5-fold for IL-4/13B1 and 78.3-fold for IL-
4/13B2 (Figure 8A). It also induced the expression of IL-
4/13A at 8 h and 24 h but to a lesser extent (up to 3.3-
fold). Similarly pathogenic R. salmoninarum (Figure 8B), 
Y. ruckeri and A. salmonicida (data not shown) all highly 
induced the expression of IL-4/13B paralogues but had 
little to no effect on the expression of IL-4/13A (Figure 
8B). 
Due to the lack of reagents to isolate T cells in fish, 
the T-cell expressing potential of IL-4/13 paralogues 
was investigated in HK cells by stimulation with a T 
cell mitogen, phytohaemagglutinin (PHA), and two trout 
recombinant (r) cytokines, rIL-2 [56] and rIL-21 [57], that 
have major effects on T cells. PHA is a potent inducer 
of IL-4/13 paralogues in HK cells (Figure 8C) as well as 
spleen leucocytes. PHA stimulation markedly increased 
the expression of IL-4/13B paralogues from 4 h (53.0-
fold for IL-4/13B1 and 91.0-fold for IL-4/13B2) to 96 
h that peaked at 8 h for IL-4/13B2 (236.7-fold) and 24 
h for IL-4/14B1 (222.3-fold). PHA also increased the 
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Figure 6: Modulation of the expression of trout IL-4/13A, B1 and B2 in kidney by parasite infection. Kidneys from 
rainbow trout infected with T. bryosalmonae or from unexposed (control) fish were collected during a natural infection [51-52]. The relative 
expression of IL-4/13 paralogues was normalized to the expression of EF-1α, and expressed as arbitrary units where one unit equals the 
average expression level of the control fish. Results are presented as means + SEM. The numbers of fish analysed were 12, 5, 9, 10 and 8 
representing control, grade 1, 1-2, 2, and 3, respectively. The expression levels between different groups are statistically significant (p < 
0.05) where letters over the bars are different, as tested by one way-ANOVA.
Figure 7: Modulation of the expression of rainbow trout IL-4/13A, B1 and B2 in head kidney A-C and gills (D-F) after 
vaccination and bacterial challenge. A group of fish was i.p. injected with AquaVacTM ERM (Vac), with naïve fish (Naïve) serving 
as control. The fish were challenged 60 days later by i.p. injection of Y. ruckeri (0.5 ml/fish, 1×106 cfu/ml; YR) or injected with 0.5 ml of 
PBS as control (PBS). The fish from each group were killed and the gills and HK collected for total RNA extraction. The gene expression 
analysis was performed as in Figure 4. The expression level was expressed as arbitrary units where one unit equals the average expression 
level in the PBS injected control group at 6 h in each tissue. The means + SEM of five fish are shown. The expression levels between 
different groups of the same tissue and time point are statistically different (p < 0.05) where letters over the bars are different, as determined 
by one way-ANOVA. The down arrow head indicates a significant down-regulation in the naïve fish after bacterial challenge at the same 
time point. The black line over the bars indicates a significant difference between the vaccinated and naïve fish after bacterial challenge.
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expression of IL-4/13A at 4 h and 8 h, but only up to 
4-fold. Recombinant rIL-2 increased the expression of IL-
4B paralogues from 4 h to 96 h, with a peak of induction at 
24 h for IL-4/13B2 (20.2-fold) and at 48 h for IL-4/13B1 
(49.0-fold), but had no effects on IL-4/13A expression 
(Figure 8D). rIL-21 also increased the expression of IL-
4/13B paralogues, however the effect was relatively late, 
from 8 h to 96 h, and peaked at 48 h with a 52.8 fold 
increase for IL-4/13B1 and 82.8 fold for IL-4/13B2. In 
contrast to the effect of rIL-2, rIL-21 also increased IL-
4/13A expression at a late stage (48 h and 96 h) but with 
a maximal 5.1-fold increase (Figure 8E). The induction 
of the expression of IL-4/13B paralogues by PHA, rIL-
2 and rIL-21 was observed in at least three independent 
experiments.
We further investigated the modulation of 
expression of IL-4/13 paralogues in HK macrophages. 
As potential antigen presenting cells and sensors of 
inflammatory signals from innate and adaptive immune 
responses in fish, primary trout HK macrophages 
were stimulated with PAMPs, including polyinosinic-
polycytidylic acid (poly IC, a mimic of viral infection) 
and peptidoglycan (PGN, major cell wall components of 
bacteria), and the inflammatory trout cytokines rIL-1β 
[58], rIL-6 [59], rIFNγ [29] and rTNFα [42] (Figure 9). 
IL-4/13A expression in primary macrophages was down-
regulated at early time points by poly IC, rIL-1β and 
rTNFα at 4 h, and by poly IC at 8 h, but was refractory to 
stimulation with PGN, rIL-6 and rIFNγ from 4 h to 24 h 
(Figure 9A). The expression of both IL-4/13B paralogues 
Figure 8: Modulation of the expression of rainbow trout IL-4/13A, B1 and B2 in HK cells. Freshly prepared HK cells 
were stimulated with formalin killed A. davidanieli (AD, A) and R. salmoninarum (RS, B), a T cell mitogen PHA (c), or the recombinant 
trout cytokines rIL-2 (d) and rIL-21 (e) for 4 h, 8 h 24 h, 48 h and 96 h. Quantification of gene expression was as described in Figure 4. 
Modulated expression was expressed as a fold change calculated as the mean expression levels in stimulated cells normalized to that of 
time-matched controls. The means + SEM of cells from four fish are shown. The relative significance of paired sample T tests between 
stimulated and time-matched control samples is shown above the bars. * p  ≤  0.05, **p  ≤  0.01 and ***p  ≤  0.001. 
Figure 9: Modulation of the expression of rainbow trout IL-4/13A A, B1 B and B2 C in primary HK macrophages. Four 
day old primary HK macrophages were stimulated with the PAMPs poly IC and peptidoglycan (PGN), or the recombinant cytokines rIL-1β, 
rIL-6, rIFN-γ and rTNFα for 4 h, 8 h and 24 h. Quantification of gene expression was as described in Figure 4. Modulated expression was 
expressed as a fold change calculated as the mean expression levels in stimulated cells normalized to that of time-matched controls. The 
means + SEM of cells from four fish are shown. The relative significance of paired sample T tests between stimulated and time-matched 
control samples is shown above the bars. *p  ≤  0.05. 
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was refractory at 4 h, but markedly up-regulated at 8 h and 
24 h by the PAMPs. IL-4/13B1 expression was increased 
up to 15.6-fold by poly IC and 36.5-fold by PGN (Figure 
9B). Similarly, IL-4/13B2 expression was increased up to 
13.0-fold by poly IC and 11.5 fold by PGN (Figure 9C). 
However, the expression of the IL-4/13B paralogues in 
HK macrophages was refractory to stimulation with all 
the proinflammatory cytokines tested, with the exception 
of rTNFα that up-regulated IL-4/13B2 expression at 24 h 
(5.4-fold). The bioactivity of these cytokines have been 
reported previously [29, 42, 58, 59] and are confirmed in 
this study by the modulation of a number of marker genes. 
Production and purification of bioactive 
recombinant trout Th2 cytokines
Proteins of the expected size of 15.2 kDa 
(recombinant (r)IL-4/13A), 16.5 kDa (rIL-4/13B1 (data 
not shown) and 16.8 kDa (rIL-4/13B2) were induced by 
IPTG stimulation of transformed BL21 cells, and purified 
under denaturing conditions with extensive washing in 
1% Triton X-100 buffer to remove LPS (Figure 10A). The 
purified protein was refolded in vitro and re-purified under 
native conditions, and denaturants and other contaminants 
were removed by extensive washing of the purification 
column. When the refolded proteins (up to 1000 ng/ml) 
were added to the macrophage cell line RTS-11, no up-
regulation of IL-1β and TNF-α expression (known LPS 
responsive genes in this system) was seen, confirming that 
Figure 10: SDS-PAGE analysis A and dose responses B-G of trout rIL-4/13A and rIL-4/13B2. A. SDS-PAGE analysis 
of rIL-4/13A and B expressed and purified from E. coli BL21 Star (DE3), and stained with SeeBlue (Invitrogen). 1, a sample from un-
induced BL21 cells, 2 and 4, BL21 transformed by IL-4/13A- and IL-4/13B2-expressing plasmid, respectively and induced with 1 mM 
IPTG for 4 h; 3 and 5, expression product purified from transformed cells expressing IL-4/13A and IL-4/13B2, respectively; and 6, Protein 
marker, SeeBlue Plus2 (Invitrogen). B.-G. Freshly prepared HK cells were stimulated with rIL-4/13A or rIL-4/13B2 at 0.01, 0.1, 1, 4, 16, 
64, 256, and 1000 ng/ml for 4 h. Gene expression was determined as described in Figure 4. The relative gene expression was calculated 
as the expression levels in stimulated cells normalized to that of un-stimulated controls. The means of cells from four fish are shown. For 
clarity the SEM bars are not shown here but are provided in Figure S11. The blue arrows and red arrows indicate significant differences (p 
< 0.05, paired samples T tests) after stimulation with rIL-4/13A and rIL-4/13B2, respectively. A green box indicates significantly different 
expression levels (p < 0.05, paired samples T tests) between HK cells stimulated with the same doses of rIL-4/13A or rIL-4/13B2.
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LPS contamination in the recombinant preparations was 
negligible. 
Initial analysis of bioactivity at 200 ng/ml in 
HK cells or splenocytes suggested that all the three 
recombinant proteins, rIL-4/13A, B1 and B2, were active 
in both cell populations in terms of modulation of the 
expression of several genes eg IL-4Rα1 and cathelicidin-1 
(CATH1). Due to the ease of preparation of large numbers 
of cells for in vitro stimulation, HK cells were chosen 
for further dose-response and time-course experiments. 
Also, since the IL-4/14B2 gene was more highly induced 
in vivo and in vitro (Figures 5, 6 and 8), and rIL-4/13B2 
was predicated to be more stable than rIL-4/13B1 (with 
an instability index computed to be 37.8 for rIL-4/13B2 
and 46.1 for rIL-4/13B1 [60]), and was found to be easier 
to refold, only trout rIL-4/13A and rIL-4/13B2 were taken 
further for bioactivity analysis.
A dose-response analysis of gene expression in HK 
cells suggested that both rIL-4/13A and B2 were bioactive 
at or above 0.1 ng/ml, with an increased response seen 
with increasing doses (Figure 10B-10G). Whilst the 
ability of rIL-4/13A and B2 to modulate gene expression 
of some genes, eg IFNγR1 ([61], Figure 10F) were not 
distinguishable, for other genes, eg CATH1 (Figure 10C), 
IL-4/13A was the more potent stimulant. However, for 
most of the genes analysed, eg hepcidin, IL-10b, serum 
amyloid P (SAP)1 and SOCS3 (Figure 10B, 10D, 10E, 
10G), the difference seen related to whether modulation of 
gene expression was found at lower doses (eg 1-64 ng/ml) 
or at higher doses (eg 64-256 ng/ml) with both proteins 
inducing similar responses.
Time dependent modulation of transcript 
expression by rIL-4/13A and rIL-4/13B2 in HK 
cells
A dose of 200 ng/ml was chosen for the time-course 
stimulation of HK cells for 4 h, 24 h, 48 h and 96 h, as 
both IL-4/13A and B2 had similar abilities to modulate 
the expression of the majority of genes examined in the 
dose response experiment at this concentration (Figure 
10B-10G). The expression of 64 genes were analysed 
in detail (Figures 11, 12, 13 and Table 2) in the time 
dependent experiment after an initial screening of over 
200 immune genes. Two additional early time points (2 
h and 8 h) were also analysed for several early response 
genes (Figure 11). 
Acute phase protein (APP) and antimicrobial peptide 
(AMP) genes: SAP1 expression was rapidly induced by 
rIL-4/13A with a 39.2-fold increase at 2 h, reaching the 
highest increase of 89.2-fold at 4 h and returning to control 
levels by 96 h. Its expression was also rapidly induced 
by rIL-4/13B2 with a 52.3-fold increase at 2 h, a peak of 
80.4-fold at 4 h and returning to control levels by 48 h 
(Figure 11A). SAP2 expression was also increased but to 
a lesser extent, whilst another APP (serum amyloid A) was 
down-regulated (Table 2).
Hepcidin expression was also rapidly induced by 
both rIL-4/13A and B2 and peaked at 4 h but returned to 
(or even below) control levels at 24-96 h (Figure 11B). 
CATH1 expression was increased at all time points and 
peaked at 24 h with a 26.5-fold increase for rIL-4/13A 
Figure 11: Modulation of the expression of SAP1 A, Hepcidin B and CATH1 C by rIL-4/13 isoforms. Freshly prepared 
HK cells were stimulated with rIL-4/13A or rIL-4/13B2 for 2 h to 96 h and gene expression determined as described in Figure 4. Modulated 
expression was expressed as a fold change, calculated as the expression levels in stimulated cells normalized to that of time-matched 
controls. The means + SEM of cells from four fish are shown. The relative significance of paired sample T tests between stimulated and 
time-matched control cell cultures are shown above the bars as: *p  ≤  0.05, **p  ≤  0.01 and ***p  ≤  0.001. The black lines over the bars 
indicate significantly different expression levels between HK cells stimulated with rIL-4/13A and rIL-4/13B2.
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and a 6.5-fold increase for rIL-4/13B2 (Figure 11C). 
However, CATH2, that has a lower constitutive expression 
level, was down-regulated (Table 3). It is clear that the 
ability to modulate APP and AMP gene expression by rIL-
4/13A and B2 differ in a gene- and time-dependent manner 
(Figure 11).
Cytokine receptors: Both rIL-4/13A and B2 were 
able to modulate the expression of the receptors for IL-
4/13, the IL-6 cytokine family and IFNγ (Figure 12A-12J). 
Eight potential receptor subunits of IL-4/13, two each of 
IL-4Rα, γC, IL-13Rα1 and IL-13Rα2, have been identified 
in salmonids [29]. Both rIL-4/13A and B2 rapidly up-
regulated the expression of both IL-4Rα paralogues, with 
a peak of induction at 4 h by rIL-4/13B2 (10.3-fold for 
IL-4Rα1 and 3.9-fold for IL-4Rα2) and at 24 h by rIL-
4/13A (9.0-fold for IL-4Rα1 and 5.1-fold for IL-4Rα2, 
Figure 12A-12B). They also upregulated the expression 
of IL-13Rα2 paralogues at later time points (24-96 h) 
with rIL-4/13A having a more prominent effect, with a 
82.8-fold increase of IL-13Rα2a and 42.8-fold increase 
of IL-13Rα2b seen at 96 h (Figure 12E-12F). They had 
no effects on IL-13Rα1a expression, but down-regulated 
IL-13Rα1b expression at all time points (4-96 h, Figure 
12C-12D). No change of γC expression was seen in the 
screening.
Both rIL-4/13A and B2 also rapidly up-regulated 
the expression of IFNγR1 [61], with a peak at 4 h (4.7-
fold for rIL-4/13A and 5.6-fold for IL-4/13B2), but were 
less effective for IFNγR2 expression (Figure 12G-12H). 
The expression of GP130 [62], a signal receptor chain for 
the IL-6 family cytokines, was up-regulated to a moderate 
degree from 4-96 h by both cytokines. In contrast, the 
expression of IL-6Rα, the private chain of IL-6, was 
down-regulated at 48 h by rIL-4/13A (Figure 12I-12J). 
Figure 12: Modulation of the expression of the cytokine receptors for IL-4/13 (IL-4α1 and α2, IL-13Rα1a and α1b, 
and IL-13Rα2a and α2b), IFNγ (IFNγR1 and 2), IL-6 (IL-6Rα and GP130) and MCSF (MCSFR1 and 2), and cellular 
markers for T cells (CD4-1, CD8α and CD8β) and dendritic cells (CD83, CLEC4, and CD209L2) by rIL-4/13 isoforms. 
Freshly prepared HK cells were stimulated with rIL-4/13A or rIL-4/13B2 for 4 h to 96 h and gene expression determined as described in 
Figure 11. The means + SEM of cells from four fish are shown. The relative significance of paired sample T tests between stimulated and 
time-matched control cell cultures are shown above the bars as: *p ≤ 0.05, **p ≤ 0.01 and ***p ≤ 0.001. The black lines over the bars 
indicate significantly different expression levels between HK cells stimulated with recombinant rIL-4/13A and rIL-4/13B2.
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Curiously, they up-regulated at early time points (4-48 h) 
the expression of MCSFR2, that is highly expressed in HK 
primary macrophages but down-regulated the expression 
of the more lowly expressed MCSFR1 paralogue (Figure 
12K-12L).
Cellular marker genes: HK cells are comprised of 
immune cell types, including T cells, B cells, macrophages/
dendritic cells. The expression of marker genes of these 
cell populations was examined during the course of rIL-
4/13 stimulations. CD4-1 expression was increased at 
24-96 h by rIL-4/13A (up to 3.7-fold) and at 48 h by IL-
4/13B2 (2.2-fold) (Figure 12M). A small increase of the 
expression of CD8α and CD8β was observed at 4 h by rIL-
4/13A and rIL-4/13B2, respectively (Figure 12N-12O). 
The expression of the master transcription factors for Th 
cell development, T-bet, GATA3 [63], FoxP3 [64] and 
RORγ [65], and T cell co-receptors, CD28 and CTLA, 
were not modulated relative to time-matched controls or 
were changed marginally at some time points (Table 2). 
The expression of B cell markers, the membrane form 
of IgM, IgT and IgD, and the secreted form of IgM and 
IgD was refractory to rIL-4/13 proteins. However, a 
small increase (less than 2-fold) in secreted IgT transcript 
expression was observed at 4 h and 48 h by IL-4/13B2 
(Table 2). 
Several genes relevant to the function of antigen-
presenting cells (macrophages/dendritic cells) were 
induced. CD83 [66] expression was rapidly induced at 
4-48 h by rIL-4/13B2 with a peak at 4 h with a 9.3-fold 
increase, and by rIL-4/13A at 24 h (Figure 12P). The 
expression of CLEC4, a trout DC-SIGN/CD209 like 
molecule [67] was also rapidly induced at 4-96 h and 
peaked at 4 h (4.8-fold) with rIL-4/13A stimulation, and 
to a lesser extent by rIL-4/13B2 at 4 h and 96 h (Figure 
12Q). Another CD209 like molecule (CD209L2) was also 
found to be up-regulated by both rIL-4/13 proteins at the 
later time points (48-96 h) (Figure 12R). The expression 
of CD209L1, and the MHC class II beta chain was 
refractory to IL-4/13 stimulation. However, small changes 
in expression of other genes, ie LAMP3 [68], CD80/86 
Table 2: Fold change of transcript expression after stimulation of HK cells with rIL-4/13A and rIL-4/13B2. 
Numbers in red indicate significant (p<0.05, paired sample T tests) up-regulation, in blue down-regulation and in black no 
change. The numbers highlighted in green at the same time point indicate significant differences between samples stimulated 
with rIL-4/13A and rIL-4/13B2.
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Figure 13: Modulation of the expression of the pro-inflammatory cytokines (IFNγ1 and 2, IL-1β1 and LECT2), anti-
inflammatory cytokines (IL-10a and b) and negative regulators (SOCS3) by rIL-4/13 isoforms. Freshly prepared HK 
cells were stimulated with rIL-4/13A or rIL-4/13B2 for 4 h to 96 h and gene expression determined as described in Figure 11. The means 
+ SEM of cells from four fish are shown. The relative significance of paired sample T tests between stimulated and time-matched control 
cell cultures are shown above the bars as: *p  ≤  0.05, **p  ≤  0.01 and ***p  ≤  0.001. The black lines over the bars indicate significantly 
different expression levels between HK cells stimulated with recombinant rIL-4/13A and rIL-4/13B2.
Figure 14: Effects of rIL-4/13 isoforms on IgM+ B cells. A. Spleen leucocytes were incubated with/without rIL-4/13A (200 ng/
ml), rIL-4/13B2 (200 ng/ml), LPS (100 µg/ml), or LPS in combination of rIL-4/13A or IL-4/13B2 for 3 days at 20ºC and IgM secreting cells 
were determined by ELISPOT. The IgM secreting B cells (means + SEM, n = 5) relative to control ( = 1) are shown. B-D. Spleen leucocytes 
were incubated with/without rIL-4/13A, rIL-4/13B2, or LPS as positive control for 3 days at 20ºC. The proliferating cells were then labeled 
with BrdU and incubated for a further 24 h. The proliferating (BrdU+) cells and IgM+ B cells were then determined by flow cytometry with 
typical results shown in Figure S12. The relative number (means + SEM, n = 11) of IgM+ B cells (b), proliferating B cells (BrdU and IgM 
double positive, C) and total proliferating cells (BrdU+, D) are shown. E-H. Spleen leucocytes (n = 6) were incubated with/without rIL-
4/13A, rIL-4/13B, or LPS as positive control for 24 h at 20ºC. IgM+ cells were sorted into TRIzol. The relative transcript expression (means 
+ SEM, n = 6) of the membrane form of IgM heavy chain (e), secretory form of IgM heavy chain (F), CATH1 (G) and IL-1β (H) in FACS 
sorted IgM+ B cells are shown. The relative significance of paired sample T tests between stimulated and control samples are shown above 
the bars as: *p  ≤  0.05 **p  ≤  0.01 and ***p  ≤  0.001.
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[69] and MHC class I, were seen at the late time points 
(Table 2).
Cytokines and suppressor of cytokine signalling 
(SOCS) genes
Induced changes in cytokine gene expression of 
the paralogues of IL-4/13, TGF-β1, TNFα and IL-8 were 
minor (Table 2), but for IFNγ, IL-1β and IL-10 they were 
relatively large and will be described in more detail. 
Two IFN-γ paralogues are present in salmonids. IFNγ1 
expression was down-regulated at 24-96 by rIL-4/13A and 
at 96 h by rIL-4/13B2. Similarly, IFNγ2 expression was 
down-regulated at 48-96 h by rIL-4/13A and at 4 h and 96 
h by rIL-4/13B2 (Figure 13A-13B). 
Three IL-1β paralogues are present in salmonids 
with IL-1β1 highly expressed in HK cells and HK 
primary macrophages [41]. IL-1β1 expression was also 
significantly down-regulated at 48-96 h by rIL-4/13A and 
at 24 h and 96 h by rIL-4/13B2 (Figure 13C). 
LECT2 (Leukocyte cell-derived chemotaxin-2) 
acts as a chemotactic factor for neutrophils and promotes 
inflammation and activation of macrophages [70-71]. 
LECT2 expression was significantly down-regulated from 
24 h to 96 h by both rIL-4/13 proteins (Figure 13D)
Two paralogues of the anti-inflammatory cytokine 
IL-10 are present in salmonids [72]. Low level induction 
of IL-10a expression was observed at 48 h by rIL-4/13A 
and at 96 by rIL-4/13B2 (Figure 13E). In contrast, a 
prominent induction of IL-10b expression was observed 
from 4-96 h by both cytokines, that peaked at 24 h (7.1-
fold) for rIL-4/13B2 stimulation and at 96 h (25.2-fold) for 
rIL-4/13A stimulation (Figure 13G). The rIL-4/13 proteins 
also induced the expression of another anti-inflammatory 
cytokine TGF-β1 but with less potency (Table 2).
SOCS are cytokine-inducible negative regulators 
of cytokine signaling. SOCS3 [73] expression was highly 
induced from 4-96 h and peaked at 24 h with a 30.3-fold 
increase for rIL-4/13A stimulation and a 18.5-fold increase 
for rIL-4/13B2 stimulation (Figure 13F). A small increase 
of SOCS2 expression was also seen but no change in 
SOCS1 expression occurred with either protein (Table 2).
Rainbow trout IL-4/13 isoforms increase IgM 
secreting B cells but have no effects on IgM+ b 
cell proliferation in vitro
Previous analysis revealed that trout B cells 
isolated from spleen expressed higher levels of potential 
receptor subunits of IL-4/13 isoforms, e.g. IL-4Rα2, γC1 
and IL-13Rα2a [29], compared to B cells isolated from 
blood and head kidney. There are more IgM+ B cells in 
the lymphocyte population in spleen (30.3%) than in the 
HK (12.4%) [74]. Thus, B cells from spleen were used 
throughout this study. A mean of 160 IgM secreting 
cells could be detected in each well of control cells (n 
= 5) by ELISPOT. No significant effects were observed 
when the cytokines and LPS were added alone. However, 
the combination of LPS with rIL-4/13A or rIL-4/13B2 
significantly increased the number of IgM secreting B 
cells (Figure 14A). We further analysed the potential 
of these cytokines to induce IgM+ B cell proliferation 
(n = 11). In the control cells, the average IgM+, BrdU+/
IgM+ and BrdU+ cells were 29.44%, 0.35% and 1.02%, 
respectively (Figure S12). Unexpectedly, neither IgM+ 
cells nor proliferating IgM+ cells (BrdU positive) were 
increased after incubation with rIL-4/13 isoforms, despite 
a significant increase of both (1.5 fold for IgM+ cells and 
12.4 for proliferating IgM+ cells) by LPS (Figure 14B, 
14C). Furthermore, IL-4/13 isoforms had no effects on 
total BrdU positive cell numbers in spleen leucocyte 
cultures whilst LPS stimulation increased these cells by 
4.6-fold relative to the control leucocytes (Figure 14D). 
To confirm the effectiveness of these treatments, 
the expression of several marker genes was analysed 
in FACS-sorted B cells isolated from spleen leucocytes 
incubated with/without rIL-4/13A, rIL-4/13B2 and LPS 
for 24 h. Trout IL-4/13 isoforms significantly increased 
the expression of CATH1, but had no effects on transcript 
expression of IgM H-chains (membrane- and secretory 
forms), and IL-1β1 (Figure 14E-14H). As expected, LPS 
up-regulated the expression of IL-1β1 and CATH1 [42], 
down-regulated the expression of the membrane form of 
the IgM H-chain, but had no effect on the secretory IgM 
H-chain transcript. Taken together, these results show that 
the trout IL-4/13 isoforms increase IgM secreting B cell 
number but have no effects on proliferation of IgM+ B 
cells in vitro. 
dIscussIon
In this study, four genomic loci have been identified 
in salmonids and three active IL-4/13 paralogues 
belonging to the two types of fish specific type-2 IL-4/13 
genes have been cloned in both rainbow trout and Atlantic 
salmon. Our molecular characterisation of these genes 
suggests lineage-specific evolution of type 2 cytokines 
in vertebrates. We next extensively compared the 
expression and modulation of all the IL-4/13 paralogues 
in a single fish species in vivo and in vitro, providing a 
first comprehensive insight into their functional roles in 
fish. We then compared the function of the two types of 
fish-specific type-2 cytokines in fish for the first time, 
and this revealed shared but also distinct bioactivities. 
This study will facilitate a broader understanding of the 
evolution of type-2 immunity in vertebrates, the functional 
characterisation of fish-specific type-2 cytokines and the 
future potential to manipulate type-2-like immunity to 
protect fish from infectious disease.
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Lineage-specific evolution of type-2 cytokines
A single IL-4/IL-13 gene was likely to have existed 
in ancestral Gnathostomes, which has been duplicated 
in different lineages by WGD and/or tandem gene 
duplication events [10]. Thus, tandem gene duplication in 
mammals and birds led to the evolution of IL-4 and IL-13, 
and WGD in 3R teleost fish led to the IL-4/13A and IL-
13B paralogues [10, 32]. A further 4R WGD in salmonids 
potentially produced four IL-4/13 paralogues. However, 
due to pseudogenisation of one of the two IL-4/13A loci, 
only three active paralogues, IL-4/13A, B1 and B2 are 
present in Atlantic salmon and rainbow trout (Figures 1, 
S1-S7).
The IL-4, IL-13 and IL-4/13 genes are fast evolving. 
This is demonstrated by the low homology within each 
lineage and between molecules. Mammalian IL-4 and IL-
13 only share low aa identities, of 40-57% and 53-64% 
between humans, cows and mice, respectively. These 
are remarkably lower compared to mammalian IL-7 (61-
75%), IL-15 (72-78%) and IL-21 (59-68%), (Table S1). 
Furthermore, the homology between IL-4, IL-13 and 
IL-4/13 is low. For example, IL-4 and IL-13 only share 
20-23% aa identity in mammals, and 20-27% in birds. 
The cartilaginous and teleost fish IL-4/13 molecules 
share only 16-29% aa identity to mammalian IL-4 and 
15-28% identity to mammalian IL-13 (Table S1). Such 
rapid evolution is also exemplified by salmonid IL-4/13 
molecules. In a similar manner to salmonid IL-4/13, three 
paralogues of IL-1β and IL-12 p35 have also been cloned 
in both salmon and trout, which share the same origin. 
The aa identities between 4R orthologues (eg A, B1, B2), 
4R paralogues (eg B1 and B2), and 3R paralogues (eg. A 
and B1 or B2) are 90-95%, 75-79% and 29-32% for IL-1β 
molecules [41]; 95-97%, 87-90% and 36-39% for IL-12 
p35 [43]; but only 82%, 62-66% and 26-29% for IL-4/13 
molecules (Table 2), respectively.
The orthologues are typically grouped together 
and separate from the other paralogues from a WGD in 
phylogenetic tree analysis, as seen with the two types of 
IL-1β [41], TNFα [42], IL-12 [43] and CISH [75] that 
arose from the 3R WGD. However, in the case of IL-
4/13A and IL-4/13B the orthologues do not group together, 
despite a well-supported 4R WGD orthologues-grouping 
of these molecules in salmonids (Figure S9). A lineage-
specific grouping is apparent, eg bird or mammalian IL-4 
and IL-13, and IL-4/13 molecules from different teleost 
fish lineages. The gene organisation, in terms of the size 
of exon 3 (Figure 2), and disulfide bonding potential of 
the peptides (Figures 3 and S10) are also lineage-specific. 
Such data provide support for a lineage-specific evolution 
of the type-2 cytokines in different vertebrates groups.
Differential expression of the type 2 cytokines IL-
4/13A and IL-4/13B
Differential expression and modulation of the 
paralogues may suggest a sub-functionalization and/or 
neofunctionalisation [75]. Our extensive analysis of gene 
expression revealed that different isoforms of the IL-4/13 
paralogues are differentially expressed and modulated. 
Trout IL-4/13A is the major isoform highly expressed 
constitutively in tissues. Its expression is also detectable 
in all the four cell lines examined, in purified B cells, HK 
cells and primary macrophages (Figure 4). However its 
expression is less responsive to stimulation and infection 
(Figures 5, 6, 8, 9). These patterns of expression and 
modulation may suggest a homeostatic role of this IL-4/13 
isoform to provide a basal or house-keeping level of type-
2 (IL-4/13) function.
Although the constitutive expression level of IL-
4/13B1 and B2 isoforms are lower compared to that of IL-
4/13A, they are the major isoforms that are highly induced 
by viral and parasitic infection in vivo and by PAMPs in 
primary macrophages. They are also the major isoforms 
that respond to the T cell mitogen PHA and cytokines 
with major effects on T cells (Figure 8). Furthermore, IL-
4/13B1 and B2 expression is not detectable in cell lines 
of non-immune cells, or in B cells, but is present in the 
macrophage cell line RTS-11, in primary macrophages and 
in HK cells (Figure 4). These data suggest that trout IL-
4/13B1 and B2 isoforms are the major inducible isoforms 
that are expressed in T cells and other immune cells, and 
likely have a major role in T cell immunity in salmonids.
In agreement with the induced expression in vivo 
by viral and parasitic infection, the expression of trout IL-
4/13B paralogues is induced in antigen presenting cells 
(ie the primary HK macrophages) by PAMPs (Figure 9). 
In addition, HK cells were found to highly induce the 
expression of IL-4/13B paralogues in response to formalin 
killed bacteria, whether pathogenic or non-pathogenic, and 
Gram positive or Gram negative (Figure 8). These data 
show that infected rainbow trout are able to up-regulate 
IL-4/13 expression in response to PAMPs from viruses, 
parasites and bacteria. The in vivo down-regulation of IL-
4/13 paralogues in non-vaccinated fish during Y. ruckeri 
infection (Figure 7) could be indicative of mechanisms by 
which fish pathogens evade immunity.
Interestingly, the vaccinated fish expressed higher 
levels of the IL-4/13 paralogues than naïve fish during 
early stages of the disease, at 24 h and 48 h post Y. ruckeri 
infection in gills and HK (Figure 7). Whether this would 
also occur in other major secondary lymphoid organs such 
as the spleen remains to be determined. The functional 
role of IL-4/13 paralogues in this model of vaccine 
mediated protection is difficult to assess without IL-4/13 
knockout trout lines. However, perhaps if the infection is 
under control, the pathogen is unable to evade immunity in 
vaccinated fish with the expression of IL-4/13 paralogues 
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being maintained. Thus, the expression of IL-4/13 
paralogues could be utilized as a novel molecular marker 
in evaluating vaccine efficacy. This may be especially 
important when designing a multi-valent vaccine or 
vaccines to enable cross protection.
The type-2 cytokines IL-4/13A and IL-4/13B have 
overlapping but also distinct bioactivity
By sharing receptors, mammalian IL-4 and IL-13 
have overlapping but also distinct functions [1-2]. The 
orthologues of all mammalian receptor subunits are present 
in fish with two copies of each present in salmonids, which 
are differentially expressed and modulated in different 
tissues and cell lines [27-29]. Although the specific 
pairing of the ligands (three in salmonids) and receptors 
(eight in salmonids) is not clear in fish, the outcome of 
cytokine stimulation in a cell should be determined by 
1) the presence of a combination of different receptor 
subunits on cell surfaces, 2) the affinity of the ligand/
receptor binding, which will determine the strength of the 
signalling, 3) the presence of other cells that may compete 
for ligand binding (but giving a different outcome), and 4) 
the microenvironment that may contain soluble receptors 
or other molecules that can regulate ligand/receptor 
binding or signalling. 
Both rIL-4/13A and IL-4/13B2 modulated the 
expression of cellular markers of T cells and macrophages/
dendritic cells indicating these are target cells that express 
relevant receptors. This is similar to mammalian IL-4 
that acts on a variety of cell types [76]. The distinct 
bioactivities between rIL-4/13A and rIL-4/13B2 observed 
in HK cells are mainly the result of the magnitude of 
the response or differential kinetics (Figures 10, 11, 
12, 13). These differences are likely explained, at least 
in part, by differences in receptor usage or affinity to 
different receptor complexes expressed on different cell 
populations. The dissection of the mechanisms will require 
the development of new molecular tools to isolate different 
cell populations from HK cells in the future. 
AMPs and APPs are evolutionarily conserved 
effector molecules of the innate immune system that 
have important roles in the resolution of infection and 
activation of the adaptive immune response. The rapid 
up-regulation of the expression of SAP1, hepcidin and 
CATH1 by both IL-4/13A and IL-4/13B2 suggests a role 
of these type-2 cytokines in the resolution of infection. 
Rapid up-regulation of trout IL-4Rα1 and IL-4Rα2 
expression by rIL-4/13A and B2 (Figure 12) was also 
seen and may suggest a self-amplification mechanism of 
signalling specific to these cytokines. Interestingly, the 
expression of the potential decoy receptors IL-13Rα2a and 
α2b was significantly up-regulated at late stages (24-96 h) 
of stimulation of HK cells, with rIL-4/13A having more 
prominent effects compared with rIL-4/13B2 (Figure 12). 
Treatment of HK cells with rIL-4/13A and B2 
resulted in the down-regulation of the proinflammatory 
cytokines IFN-γ1, IFN-γ2 and IL-1β1, at the late time 
points, but up-regulation of anti-inflammatory genes 
including IL-10a, IL-10b, SOCS3 (Figure 13), and (to 
a lesser extent) SOCS2 (Table 2), perhaps as a negative 
feedback to limit the signalling of fish type-2 cytokines. 
Clearly these results suggest an anti-inflammatory role 
of fish type-2 cytokines, as seen with mammalian IL-4 
and IL-13 that are known to suppress the expression of 
proinflammatory genes [76]. There is also the potential 
for inhibition of Th1 type responses in fish by IL-4/13, as 
seen with IL-4 in mammals. Interestingly, the expression 
of several cytokine receptors was also affected. For 
example, IL-6R, and MCSFR1 were down-regulated, 
especially by rIL-4/13A (Figure 12). IL-6 signals via a 
complex of the common chain gp130 and the private IL-
6Rα, and is involved in inflammation and macrophage 
activation and proliferation in trout [62]. MCSFR1 and 
MCSFR2 are potentially the receptors for at least three 
fish cytokines, MCSF1, MCSF2 and IL-34, which regulate 
the mononuclear phagocyte system with crucial roles in 
inflammation, and in maintaining organismal homeostasis 
[77-78]. In contrast, IFNγR1, and to a lesser extent 
IFNγR2, MCSFR2 and gp130 were also up-regulated 
to some extent. Modulation of the expression of these 
receptors by rIL-4/13A and B2 indicates an important role 
in the fish cytokine network via cross talk with the IFN-γ 
and IL-6 family members. 
The functional role of IL-4/13 isoforms in B cells
Mammalian B cells first produce IgM and IgD and 
then, after activation, they can switch to produce IgG, IgA, 
or IgE. IL-4 can regulate Ig class switching in mice to 
IgG1 and IgE, and in humans to some subclasses of IgG 
and to IgE [79]. Teleost fish also produce IgM and IgD 
but also a unique Ig termed IgT, with IgM and IgD co-
expressed on the same cells but IgT on separate B cells 
[80]. Thus class-switching per se may not be a function of 
Th2 type cytokines in bony fish. The trout rIL-4/13A and 
B2 had no effect on transcript expression of the secreted 
or membrane forms of IgM and IgD in HK cells (Table 
2), or on the proliferation of spleen leucocytes and IgM+ 
B cells (Figure 14) in vitro. However, both cytokines 
increased the numbers of IgM secreting B cells, as seen in 
ELISPOT assays. Thus trout type-2 cytokines on their own 
have no direct proliferative effects for spleen leucocytes in 
vitro, including IgM+ B cells, but seem to be a survival or 
reactivation factor for IgM secreting B cells. Interestingly, 
in mammals, these “type-2 immune response-related” 
cytokines are not only produced by CD4 Th2 cells but also 
by ILC2s [12] that play an important role in early type-
2 responses. In mice, ILC2 can be activated in response 
to IL-4 produced by basophils releasing large amounts of 
Th2 cytokines such as IL-5 and IL-13, as well as IL-6 [81]. 
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This cytokine production together with the interaction of 
ICOS (expressed on ILC2 cells) and ICOSL (expressed on 
the surface on B lymphocytes) has been shown recently to 
increase the survival and promote the production of IgE by 
B cells [82-83]. Furthermore, IL-13 produced by ILC2 has 
been shown to activate non-dividing plasma cells [84], and 
ILC-2-derived IL-5 and IL-6 have been shown to support 
self-renewal of B1 cells from the peritoneal cavity and 
Ig production by splenic B cells [85]. This does not rule 
out the possibility that the trout type-2 cytokines could 
have proliferative effects in the presence of additional 
factors that are not present in the culture medium in vitro. 
Interestingly, a recent report in zebrafish demonstrated that 
i.p. administration of rIL-4/13A significantly increased 
the number of B cells in PBL [39]. However, whether 
the increased number of B cells is the result of IL-4/13 
proliferation effects (in vivo), or indirect effects (eg via IL-
4/13 induced factors) is not known and will be interesting 
to study further. The effects of type-2 cytokines on IgT+ B 
cells in fish also needs future investigation.
Implications towards the evolution of type-2 
immunity in early vertebrates
Th2-type immunity is hypothesised to give a fitness 
advantage by reduction of collateral tissue damage from 
metazoan parasites, and acts as a counter-regulator to Th1 
responses that are primarily antimicrobial [26]. Whilst 
Th2 responses have been known for a long time [2], there 
are still many questions relating to the mechanisms that 
initiate and control these responses in mammals [86], 
which comparative studies in other vertebrates may aid. 
There are two types of type-2 cytokines present in teleost 
fish, IL-4/13A and IL-4/13B [10], that may be further 
increased in some species by gene duplication or WGD 
(eg in salmonids, as demonstrated in this study). Fish 
type-2 cytokines have overlapping bioactivities, such as 
the induction of APPs, AMPs and IL-10, and inhibition of 
proinflammatory cytokines (IFN-γ and IL-1β), that could 
be due to conserved receptor usage [28-29] as seen in 
mammals with IL-4 and IL-13. Fish IL-4/13A is broadly 
and highly expressed and has potent bioactivities at low 
concentrations, which may provide a basal level of type-2 
immunity in fish. Fish IL-4/13B exhibits low constitutive 
levels but is highly inducible in response to PAMPs 
and T cell stimulants (mitogens and cytokines) with its 
expression perhaps being more restricted to immune 
cells. Its maximal bioactivity required relatively high 
concentration that may reflect low levels of its preferred 
receptor in unstimulated HK cells. In carp, a Th2-like cell 
clone that expresses a high level of IL-4/13B but not IL-
4/13A after PHA stimulation has been identified recently, 
supporting the concept that IL-4/13A and IL-4/13B can 
be secreted by different cell types [37]. Mammalian 
IL-4/IL-13 expression is controlled by chromatin 
remodelling in the locus control region within the 3’ end 
of the RAD50 gene, and a potential regulatory element 
within the KIF3A gene [12]. The linkage to RAD50 (IL-
4/13A) or KIF3A (IL-4/13B) likely reflects the need for 
regulatory elements associated within these genes in fish, 
but the loss of the linkage to both has perhaps impacted 
on the unique expression patterns seen in trout outlined 
above. Heterogeneity of Th2 cell responses are known in 
mammals, as seen with the so-called “inflammatory Th2 
cells” and “noninflammatory Th2 cells” [83], with interest 
in the potential to re-programme subsets that may cause 
pathology to a “protective” phenotype. Understanding 
the origins of these responses and the different Th2 
phenotypes present in other vertebrate groups may be 
informative in this regard. Overall, these data suggest an 
enhanced type-2 immunity in fish can occur following 
detection of particular danger signals and results in the 
activation and expression of the IL-4/13B gene(s), which 
may be more important for specific T cell mediated 
immunity, at least in salmonid fish. 
MATERIALS AND METHODS
Fish
Rainbow trout were maintained in aerated fibreglass 
tanks supplied with a continuous flow of recirculating 
freshwater at 14℃. Fish were fed twice daily on a 
commercial pellet diet (EWOS), and were given at least 
2 weeks of acclimatization prior to treatment. All the 
experiments described comply with the Guidelines of 
the European Union Council (2010/63/EU) for the use of 
laboratory animals, and were carried out under UK Home 
Office project licence PPL 60/4013, approved by the ethics 
committee at the University of Aberdeen.
Cloning of the IL-4/13 genes in salmonids 
Cloning of salmonid IL-4/13A cDNA and DNA
Four salmon expressed sequence tag (EST) entries 
(acc. nos. EG837624-25 and EG860817-18) were 
identified that encode for salmon IL-4/13A. To obtain 
trout IL-4/13A cDNA, primers (tIL4aF1 and 2, Table 3) 
were designed according to the salmon ESTs and used for 
3’-RACE (Rapid amplification of cDNA ends) using trout 
gill SMART cDNA, as described previously [87]. A 0.75 
kb 3’-RACE product was obtained and contained the trout 
IL-4/13A CDS and 3’-UTR. A 0.45 kb 5’-RACE product 
was obtained using primers (tIL4aR1 and R2, Table 3) 
designed on the trout IL-4/13A sequence. The overlapping 
cDNA sequence (acc. no. FN820500) contained the 5’-
UTR, complete CDS and the 3’UTR. The PCR protocol, 
cloning of the PCR product and sequence analysis was 
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as described previously [57, 78]. Fish IL-4/13A gene is 
closely linked to RAD50 [19, 32]. A 4.39 Kb genomic 
DNA (acc. no. FN820501) was amplified using primers 
located on RAD50 and in the 3’- UTR of trout IL-4/13 
cDNA. 
Cloning of salmonid IL-4/13B1 and IL-4/13B2 cDNA
The Atlantic salmon whole genome shotgun (WGS) 
sequence was searched (TBLASTN [88]) using known fish 
IL-4/13 molecules. Candidate WGS contigs (Table 1) were 
identified and exons predicted as described previously 
[43]. Primers (Table 3) were designed against the predicted 
5’-UTR and used for 3’-RACE using SMART cDNA 
as above. The cloning of the PCR products yielded full-
length cDNA sequences from two salmon IL-4/13 genes 
designated as IL-4/13B1 and IL-4/13B2, according to their 
linkage to the KIF3A gene [10, 32]. The trout counterparts 
of the salmon IL-4/13B1 and B2 were amplified from a 
mixed tissue cDNA sample using primers designed in the 
5’- and 3’- UTR of the salmon sequences (Table 3), and 
then were cloned and sequenced. The genomic sequences 
of trout IL-4/13B genes were identified from the recent 
release of the trout WGS contigs [89].
Sequence analysis
The nucleotide sequences generated were assembled 
and analyzed with the AlignIR programme (LI-COR, Inc.). 
Homology search was performed at the National Center 
for Biotechnology Information (NCBI) using the BLAST 
program (http://blast.ncbi.nlm.nih.gov/Blast.cgi) [85]. The 
gene organization was predicted using the Spidey program 
at NCBI. Protein prediction was performed using software 
at the ExPASy Molecular Biology Server (http://www.
expasy.org/tools) [60] and signal peptides were predicted 
using the SignalP4.0 program [90]. Disulfide bonding 
and cysteine connectivity were predicted using the 
DISULFIND program (http://disulfind.dsi.unifi.it) [49]. 
Global sequence comparison was performed using the 
scoring matrix BLOSUM62 within the MatGAT program, 
with a gap open penalty of 10 and gap extension penalty 
of 1. [91]. Multiple sequence alignments were generated 
using CLUSTALW [92]. The synteny of IL-4/13 loci was 
analysed using Genomicus (database version 75.01) [93]. 
A neighbour-joining phylogenetic tree was constructed 
on full-length amino acid multiple alignments using the 
MEGA6.0 software [44]. The evolutionary distances were 
computed using the JTT matrix-based method with all 
ambiguous positions removed for each sequence pair.
Transcript distribution of rainbow trout IL-
4/13 paralogues in tissues, cell lines and purified 
immune cells
RNA preparation, cDNA synthesis, and real-time 
PCR analysis were performed as described previously 
[29, 57]. The primers (Table S2) for real-time-PCR were 
designed so that at least one primer crossed an intron, to 
ensure that genomic DNA could not be amplified under the 
PCR conditions used. To directly compare the expression 
level of the different IL-4/13 paralogues, a reference was 
constructed using equal molar amounts of PCR product 
from each gene, including the house keeping gene 
elongation factor-1α (EF-1α). The relative expression level 
of each sample was normalized against the expression 
level of EF-1α.
Tissues from healthy fish 
Six healthy rainbow trout (~140 g) were killed 
and seventeen tissues (blood, thymus, gills, scales, 
skin, muscle, tail fins, adipose fin, brain, adipose tissue, 
spleen, liver, heart, intestine, gonad, head kidney and 
caudal kidney) were collected and processed as described 
previously [41, 94]. The RNA preparation, cDNA 
synthesis and real-time PCR analysis of gene expression 
was also as described previously [29, 61].
Cell lines, head kidney (HK) cells, primary 
macrophages and purified IgM+ b cells
Four rainbow trout cell lines, a monocyte/
macrophage-like cell line RTS-11 from spleen [95], 
an epithelial cell line RTL from liver [96], and fibroid 
cell lines RTG-2 from gonad [97] and RTGill from 
gills [98], were cultured in Leibovitz medium (L-
15, Life Technologies) supplemented with 100 IU/ml 
penicillin/100 μg/ ml streptomycin (P/S), and 10% fetal 
calf serum (FCS). The cells were dissolved in TRI reagent 
(Sigma) for total RNA preparation, with real-time RT-PCR 
quantification of gene expression performed as above. 
Preparation of HK cells, primary macrophages and B cells 
will be described in the next section.
Preparation of HK cells, primary HK 
macrophages, spleen leucocytes and IgM+ b cells
Heparinized blood was extracted from freshly killed 
rainbow trout and HK and spleen tissue then collected 
and placed into L-15 medium supplemented with P/S, 
10 units/ml heparin and 5% FCS. Single cell suspensions 
were generated using 100 μm nylon cell strainers (BD 
Biosciences). The HK cells were then washed and used 
directly for in vitro stimulation [57] or for preparation of 
primary macrophages as described previously [59]. To 
prepare spleen leucocytes, the splenocytes were placed 
onto 30%/51% Percoll (GE Healthcare) discontinuous 
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density gradients and then centrifuged at 500 g for 30 
min at 4ºC. The interface cells were collected and washed 
twice with L-15 containing 5% FCS. The IgM+ B cells 
were purified by FACS sorting of spleen leucocytes using 
an anti-trout IgM mAb (1.14) [74].
Expression of trout IL-4/13 paralogues during 
viral infection
VHSV has been isolated from more than 60 fish 
species, with rainbow trout the most susceptible [50]. The 
kidney is one of the major targets of VHSV infection, 
and thus the expression was examined in the kidney. The 
pathogenic VHSV strain DK-F1 was used for infection 
and the challenge performed as described previously [57, 
99]. Fish were i.p. injected with 1 x 108 TCID50/fish or 
the equivalent volume of medium alone as a control. Four 
fish from each group were killed at 1, 2, 3, 4, 5, 7, 9 and 
12 days post-infection and HK tissues collected. Real-time 
PCR analysis was conducted as described above.
Expression of trout IL-4/13 paralogues during 
parasitic infection
T. bryosalmonae infects salmonid fish primarily via 
the gill epithelia, subsequently gaining access to internal 
tissues via the vascular system, with the kidney being the 
main target organ [51]. Trunk kidney tissue collection 
and cDNA preparation was as described previously [52]. 
The severity of clinical pathology was analysed and a 
kidney swelling grade assigned to each fish according 
to the kidney swelling index system devised by Clifton-
Hadley and colleagues [51]. Real-time PCR analysis was 
conducted as described above.
Modulation of the expression of trout IL-4/13 
paralogues by vaccination and bacterial challenge
Archived material of a vaccination and challenge 
experiment against ERM [53] was used. Briefly, a group 
of 50 trout were vaccinated with AquaVacTM ERM by i.p. 
injection of 0.1 ml of vaccine as recommended by the 
manufacturer (Intervet Schering-Plough). An additional 
group of 50 trout that were handled in the same way but 
without vaccination served as controls. The fish were 
left for 60 days and then challenged by i.p. injection of 
a pathogenic strain (MT3072) of Y. ruckeri (0.5 ml/fish, 
1×106 cfu/ml) or 0.5 ml of PBS as control. This dose of 
MT3072 has been shown to kill ~90% of fish in previous 
independent pre-experimental tests, with mortalities 
occurring from day 3. In this trial four groups of 25 
fish were established; the control fish injected with PBS 
(Naïve/PBS), or Y. ruckeri (Naïve/YR), and vaccinated 
fish injected with PBS (Vac/PBS) or Y. ruckeri (Vac/YR). 
Five fish from each group were killed at 6 h, 24 h, 48 
h and 72 h after challenge/PBS injection, to assess the 
responses prior to the expected onset of mortalities in the 
Naïve/YR group. The head kidney and gills were collected 
for gene expression analysis as above.
Modulation of the expression of trout IL-
4/13 paralogues in HK cells and primary HK 
macrophages
Freshly prepared HK cells (isolated as described 
above) were stimulated with formalin killed A. davidanieli 
(100 µg/ml, wet weight), R. salmoninarum (100 µg/ml), 
A. salmonicida (100 µg/ml) and Y. ruckeri (100 µg/ml); 
a T cell mitogen (PHA at 5 µg/ml), and two recombinant 
cytokines (rIL-2 at 200 ng/ml [56] and rIL-21 at 100 ng/
ml) [57] for 4 h, 8 h, 24 h, 48 h and 96 h. Four day old 
primary HK macrophages [59] were stimulated with 
PAMPs (poly I:C at 50 µg/ml and peptidoglycan (PGN) 
at 10 µg/ml), and recombinant trout cytokines (rIL-1β 
at 20 ng/ml [58], rIL-6 at 200 ng/ml [59], rIFN-γ at 20 
ng/ml [29], and TNFα at 10 ng/ml [42]) for 4 h, 8 h and 
24 h. The concentration chosen for each stimulant was 
deemed optimal for immune gene expression studies based 
on our previous work [29, 42, 56-59]. The stimulation 
was terminated by dissolving the cells in TRI reagent 
(Sigma, UK). Quantification of gene expression was as 
described above. Modulated expression was expressed 
as a fold change calculated as the mean expression levels 
in stimulated cells normalized to that of time-matched 
controls. 
Cloning, expression and purification of 
recombinant trout IL-4/13 isoforms
Cloning
The sequences encoding the mature peptides of trout 
IL-4/13 isoforms were amplified from cloned cDNA using 
the primers detailed in Table 3. The amplified products 
were cloned to a pET vector (Novagen) as described 
previously [57, 59]. Each construct has an ATG codon 
added at the N-terminus for translation initiation and a 
sequence encoding for GSGHHHHHHHH added at the 
C-terminus for purification. Thus, the recombinant trout 
IL-4/13A, B1 and B2 were 133 aa, 145 aa and 148 aa, 
with a calculated molecular weight/theoretical pI of 
15.15 kDa/7.25, 16.51 kDa/7.82 and 16.76 kDa/7.75, 
respectively. 
Expression and purification of trout IL-4/13 isoforms
For each protein a sequence confirmed plasmid 
was transformed into BL21 Star (DE3) competent cells 
(Invitrogen). The induction of recombinant protein 
production, purification under denaturing conditions, 
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refolding, re-purification under native conditions, 
SDS-PAGE analysis of proteins and quantification of 
protein concentration were as described previously 
[57, 59, 100]. The refolding buffer contained 25 mM 
MES (MW), pH6.5 (6.5), 25% glycerol, 0.6 M arginine 
monohydrochloride, 0.5% Triton-100, 0.2% PEG3350, 10 
mM 2-mercaptoethanol and 1 mM EDTA. The purified 
proteins were desalted in desalting buffer (DSB) (50 
mM Hepes, pH7.0, 140 mM NaCl, 10 mM arginine, 
50% glycerol and 5 mM 2-ME) using PD-10 Desalting 
Columns (GE Healthcare). After sterilization with a 0.2 
µm filter, the recombinant proteins were aliquoted and 
stored at -80oC ready for stimulation of cells.
Modulation of gene expression in HK cells by 
recombinant trout IL-4/13 isoforms
The recombinant proteins produced above were 
initially added to HK cells and splenocytes (2x106 cells/
ml) at 200 ng/ml for different times (4 h to 24 h) to test 
their bioactivity in terms of modulating gene expression 
as described previously [42, 101]. Further tests were 
conducted using HK cells with different doses (0.01 ng to 
1,000 ng/ml) for 4 h, or 200 ng/ml of recombinant proteins 
for different times (2 h to 96 h). The experiments were 
terminated by dissolving the cells in TRI reagent and real-
time PCR analysis was conducted as described above. 
After an initial screening of over 200 genes, the expression 
of 62 trout immune genes, including those encoding for 
cellular markers, cytokines and cytokine receptors, were 
analysed in the time course experiment using primers 
detailed in Table S2. 
Table 3: Primers used for cloning, expression analysis and recombinant protein production of 
salmonid IL-4/13A and IL-4/13B genes 
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The Enzyme-Linked ImmunoSpot (ELISPOT) 
assay
ELISPOT was used to quantify the number of IgM-
secreting B cells. ELISPOT plates containing Inmobilon-P 
membranes (Millipore) were activated with 70% ethanol 
for 30 s, coated with anti-trout IgM mAb (clone 4C10) at 2 
µg/ml, diluted in PBS and incubated overnight at 4°C. To 
block non-specific binding to the membrane, plates were 
then incubated with PBS containing 2% bovine serum 
albumin (BSA) for 2 h at room temperature. Stimulated 
(with rIL-4/13A, rIL-4/13B2, LPS, or LPS in combination 
with rIL-4/13A or rIL-4/13B2) or unstimulated splenocytes 
from individual fish were added to the wells in triplicate 
at a concentration of 1 x 105 cells per well. After 72 h of 
incubation at 20ºC, cells were washed away 5 times with 
PBS and plates were blocked again with 2% BSA in PBS 
for 1 h at room temperature. After blocking, biotinylated 
anti-trout IgM mAb (clone 4C10) was added to the plates 
and incubated at 1 µg/ml for 1 h at room temperature. 
Following additional washing steps (5 times in PBS) the 
plates were developed using streptavidin-HRP (Thermo 
Scientific) for 1 h at room temperature, washed again 
with PBS and incubated with 3-amino 9-ethylcarbazole 
(Sigma Aldrich) for 30 min at room temperature in the 
dark. Substrate reaction was stopped by washing the 
plates with tap water. Once the membranes had dried, they 
were digitally scanned and spot counts determined by the 
ImmunoSpot Series 45 Micro ELISPOT Analyzer. 
Cell proliferation assay
A BrdU Flow Kit (Becton Dickinson) was used 
to measure the specific proliferation of IgM+ cells 
following the manufacturer´s instructions. Splenocytes 
at a concentration of 2 x 106 cells/ml were incubated for 
3 days at 20 ºC with different stimuli (rIL-4/13A, rIL-
4/13B2 or LPS as a positive control). Bromodeoxyuridine 
(BrdU, 10 µM) was then added to the cultures and cells 
were incubated for an additional 24 h. Afterwards the 
cells were collected and stained with a phycoerythrin 
(PE) conjugated anti-trout IgM mAb (1.14), then fixed 
and permeabilized with Cytofix/Cytoperm Buffer for 15 
min on ice. Next the cells were incubated with Cytoperm 
Permeabilization Buffer Plus for 10 min on ice and re-
fixed with Cytofix/Cytoperm Buffer for 5 min at room 
temperature. Cells were then incubated with DNase (30 
µg/106 cells) for 1 h at 37 ºC, to expose the incorporated 
BrdU. Finally, they were stained with a FITC conjugated 
anti-BrdU antibody for 20 min at room temperature 
and analysed by flow cytometry (BD FACSCalibur, BD 
Biosciences). 
Cell sorting
Splenocytes from individual fish were dispensed 
into 24-well plates at a density of 1 x 106 cells/ml and 
incubated with rIL-4/13A, rIL-4/13B2 or LPS as a 
reference. Non-stimulated controls were also included. 
Cells were then incubated at 20ºC for 24 h. The leucocytes 
were then collected from the wells by gentle scrapping, 
resuspended in PBS and incubated for 30 min on ice 
with a PE conjugated anti-trout IgM mAb (1.14) [74]. 
Following two washing steps, cells were resuspended in 
PBS and IgM+ cells were isolated by FACS sorting in a 
BD FACSAria III (BD Biosciences), using first their FSC/
SSC profiles (to exclude the granulocyte gate) and then on 
the basis of the fluorescence emitted by the anti-trout IgM 
mAb [102]. IgM+ and IgM- cells were then collected in 
different tubes for RNA isolation. Expression of IgM and 
the absence of T cell markers (CD3 and TCR) was verified 
by PCR in selected samples to confirm effective sorting.
statistical analysis
The data were statistically analyzed using the SPSS 
Statistics package 22 (SPSS Inc., Chicago, Illinois). The 
analysis of real-time PCR data was as described previously 
[29, 57]. One way-analysis of variance (ANOVA) and the 
LSD post hoc test were used to analyse expression data 
derived from the infection studies, with p < 0.05 between 
treatment and control groups considered significant. 
For the tissue distribution of expression and in vitro 
experiments that consisted of sample sets from individual 
fish, a Paired-Samples T-test was applied. 
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